111.39
+1.16(+1.05%)
Currency In USD
| Previous Close | 110.23 |
| Open | 109.4 |
| Day High | 112.1 |
| Day Low | 108.72 |
| 52-Week High | 195.36 |
| 52-Week Low | 102.58 |
| Volume | 355,537 |
| Average Volume | 605,139 |
| Market Cap | 4.92B |
| PE | -15.56 |
| EPS | -7.16 |
| Moving Average 50 Days | 121.08 |
| Moving Average 200 Days | 127.65 |
| Change | 1.16 |
If you invested $1000 in Teleflex Incorporated (TFX) 10 years ago, it would be worth $896.28 as of November 25, 2025 at a share price of $111.39. Whereas If you bought $1000 worth of Teleflex Incorporated (TFX) shares 5 years ago, it would be worth $304.49 as of November 25, 2025 at a share price of $111.39.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Teleflex to Present at the Jefferies Global Healthcare Conference in London
GlobeNewswire Inc.
Nov 14, 2025 11:30 AM GMT
WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT). A live audio webcast of
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
GlobeNewswire Inc.
Oct 16, 2025 8:30 PM GMT
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025. To
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
GlobeNewswire Inc.
Sep 11, 2025 10:30 AM GMT
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting StentsWAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the en